In-Stent Stenosis After Pipeline Embolization Device in Intracranial Aneurysms: Incidence, Predictors, and Clinical Outcomes.

Mirzat TurhonHuibin KangJian LiuYisen ZhangYing ZhangJiliang HuangKun WangMengxing LiJianmin LiuHongqi ZhangTianxiao LiDonglei SongYuanli ZhaoBin LuoAierpati MaimaitiMaimaitili AishaYunyan WangWenfeng FengYang WangJieqing WanGuohua MaoHuaizhang ShiXinjian YangSheng Guan

Published in: Neurosurgery (2022)

ISS occurs in approximately 10.03% of cases at a mean follow-up of 9 months. Statistically, current smoking history and cerebral atherosclerosis are the main predictors of ISS. Severe ISS may be associated with higher risk of neurological ischemic events in patients with IA after pipeline embolization device implantation.

Keyphrases

cerebral ischemia
subarachnoid hemorrhage
cardiovascular disease
risk factors
early onset
ischemia reperfusion injury
type diabetes
blood brain barrier
brain injury
oxidative stress
drug induced